GENETIC ABLATION OF THE PRP GENE CELLS USING A TARGETED PROMOTER TRAP STRATEGY FOR PRODUCTION OF SERUM-FREE RECOMBINANT PROTEINS AS THERAPEUTICALS - Patent 2084269

(19)

(11)

EP 2 084 269 A2

(12)

(88)	Date of publication A3:
	10.07.2008

(43)	Date of publication:
	05.08.2009 Bulletin 2009/32

(21)	Application number: 07847234.7

(22)	Date of filing: 20.11.2007

(51)

International Patent Classification (IPC):

C12N 5/10^(2006.01)

C12N 5/06^(2006.01)

(86)	International application number:
	PCT/EP2007/062597

(87)	International publication number:
	WO 2008/061995 (29.05.2008 Gazette 2008/22)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK RS

(30)

Priority:

20.11.2006 EP 06124427

(71)	Applicant: Octagene GmbH
	82152 Martinsried (DE)

(72)	Inventors:
	SCHRÖDER, Carola 82061 Neuried (DE) CASADEMUNT, Elisabeth 81241 München (DE) BJÖRNSTRUP, Kim 8835 Feusisberg (CH)

(74)	Representative: Schreiber, Christoph
	Patentanwälte von Kreisler Selting Werner Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln 50667 Köln (DE)

(54)	GENETIC ABLATION OF THE PRP GENE CELLS USING A TARGETED PROMOTER TRAP STRATEGY FOR PRODUCTION OF SERUM-FREE RECOMBINANT PROTEINS AS THERAPEUTICALS